Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronan Roussel

Showing results (101-110 of 202) with videos related to

Pageof 21
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2013
Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetesLouis Potier, Ludovic Waeckel, Marie-Pascale Vincent, et al.
Journal of Clinical Lipidology|September 29, 2016
Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levelsBoris Hansel, Dominique Bonnefont-Rousselot, Alexina Orsoni, et al.
Nature Medicine|April 7, 2007
NMR-based prediction of cardiovascular risk in diabetesRonan Roussel, France Mentré, Nadia Bouchemal, et al.
Cardiovascular Diabetology|August 4, 2018
Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetesGilberto Velho, Stéphanie Ragot, Ray El Boustany, et al.
European Journal of Preventive Cardiology|May 1, 2014
Interaction between diabetes and a high ankle-brachial index on mortality riskLouis Potier, Ronan Roussel, Julien Labreuche, et al.
Metabolism: Clinical and Experimental|March 26, 2015
ABCG8 polymorphisms and renal disease in type 2 diabetic patientsAnthony Nicolas, Sehrish Fatima, Amel Lamri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetesRiphed Jaziri, Roberte Aubert, Ronan Roussel, et al.
Genes and Immunity|November 18, 2023
Genetic variants of interferon-response factor 5 are associated with the incidence of chronic kidney disease: the D.E.S.I.R. studyFrédéric Fumeron, Gilberto Velho, Fawaz Alzaid, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2018
Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patientsCharlyne Carpentier, Séverine Dubois, Kamel Mohammedi, et al.
Diabetes Care|April 8, 2021
<i>ACE</i> I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 DiabetesYawa Abouleka, Kamel Mohammedi, Charlyne Carpentier, et al.
Pageof 21

Showing results (101-110 of 202) with videos related to

Sort By:
Pageof 21
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2013
Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetesLouis Potier, Ludovic Waeckel, Marie-Pascale Vincent, et al.
Journal of Clinical Lipidology|September 29, 2016
Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levelsBoris Hansel, Dominique Bonnefont-Rousselot, Alexina Orsoni, et al.
Nature Medicine|April 7, 2007
NMR-based prediction of cardiovascular risk in diabetesRonan Roussel, France Mentré, Nadia Bouchemal, et al.
Cardiovascular Diabetology|August 4, 2018
Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetesGilberto Velho, Stéphanie Ragot, Ray El Boustany, et al.
European Journal of Preventive Cardiology|May 1, 2014
Interaction between diabetes and a high ankle-brachial index on mortality riskLouis Potier, Ronan Roussel, Julien Labreuche, et al.
Metabolism: Clinical and Experimental|March 26, 2015
ABCG8 polymorphisms and renal disease in type 2 diabetic patientsAnthony Nicolas, Sehrish Fatima, Amel Lamri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetesRiphed Jaziri, Roberte Aubert, Ronan Roussel, et al.
Genes and Immunity|November 18, 2023
Genetic variants of interferon-response factor 5 are associated with the incidence of chronic kidney disease: the D.E.S.I.R. studyFrédéric Fumeron, Gilberto Velho, Fawaz Alzaid, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2018
Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patientsCharlyne Carpentier, Séverine Dubois, Kamel Mohammedi, et al.
Diabetes Care|April 8, 2021
<i>ACE</i> I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 DiabetesYawa Abouleka, Kamel Mohammedi, Charlyne Carpentier, et al.
Pageof 21